Counterfeit Drugs

Counterfeit Drugs

Evidence of a fake anti-cancer drug in the U.S. raises new concerns: Efforts to safeguard prescription medications.

The FDA is investigating a fake supply of the anti-cancer drug Avastin that made its way into U.S. doctors' offices and medical clinics. The agency does not believe anyone was harmed by the counterfeit product. And it sought to reassure the American public about the safety of the medicines we take. But the fake-Avastin case follows similar ones involving the cholesterol drug Lipitor, a popular weight-loss pill and Viagra. And it has heightened concern that counterfeit medicine is a growing problem in the U.S. An estimated 80 percent of the active ingredients in U.S. medicines comes from overseas, making regulation more difficult. Diane and her guests talk about keeping the U.S. drug supply safe.


Ilisa Bernstein

acting director, FDA Center for Drug Evaluation and Research, Office of Compliance.

Gardiner Harris

science reporter for The New York Times and author of the mystery novel "Hazard."

Frank Palumbo

executive director of the University of Maryland School of Pharmacy Center on Drugs and Public Policy.

Heather Bresch

CEO, Mylan.

William Hubbard

former associate commissioner for the Food and Drug Administration.

Related Items

Please familiarize yourself with our Code of Conduct and Terms of Use before posting your comments.

Our address has changed!

The Diane Rehm Show is produced by member-supported WAMU 88.5 in Washington DC.